Cessatech A/S (NGM:CESSA)

Market Cap	286.87M
Revenue (ttm)	n/a
Net Income (ttm)	-23.10M
Shares Out	18.58M
EPS (ttm)	-1.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,970
Average Volume	16,552
Open	10.62
Previous Close	10.66
Day's Range	10.38 - 10.64
52-Week Range	6.00 - 15.95
Beta	0.51
RSI	43.01
Earnings Date	Nov 13, 2025

About Cessatech

Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CESSA

Financial Performance

Financial numbers in DKK